GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt,Andrew D Oxman,Gunn Elisabeth Vist,Regina Kunz,Yngve Falck-Ytter,Pablo Alonso-Coello,Holger J. Schünemann +6 more
Reads0
Chats0
TLDR
The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.Abstract:
Guidelines are inconsistent in how they rate the quality of evidence and the strength of recommendations. This article explores the advantages of the GRADE system, which is increasingly being adopted by organisations worldwideread more
Citations
More filters
Journal ArticleDOI
Spinal manipulative therapy for chronic low‐back pain
Sidney M. Rubinstein,Marienke van Middelkoop,Willem J J Assendelft,Michiel R. de Boer,Maurits W. van Tulder +4 more
TL;DR: High quality evidence suggests that there is no clinically relevant difference between SMT and other interventions for reducing pain and improving function in patients with chronic low-back pain.
Journal ArticleDOI
Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children
Hania Szajewska,Roberto Berni Canani,Alfredo Guarino,Iva Hojsak,Flavia Indrio,Sanja Kolaček,Rok Orel,Raanan Shamir,Yvan Vandenplas,Johannes B. van Goudoever,Zvi Weizman +10 more
TL;DR: Recommendations are provided for the use of probiotics for the prevention of antibiotic-associated diarrhea in children based on a systematic review of previously completed systematic reviews and of randomized controlled trials published subsequently to these reviews.
Journal ArticleDOI
Clinical report - Guidelines for the determination of brain death in infants and children: An update of the 1987 task force recommendations
TL;DR: Determination of brain death in term newborns, infants and children is a clinical diagnosis based on the absence of neurologic function with a known irreversible cause of coma.
Journal ArticleDOI
Oxygen therapy for acutely ill medical patients: a clinical practice guideline.
Reed A C Siemieniuk,Derek K. Chu,Lisa Ha-Yeon Kim,Maria-Rosa Güell-Rous,Waleed Alhazzani,Paola M. Soccal,Paul J. Karanicolas,Pauline Darbellay Farhoumand,Jillian L K Siemieniuk,Imran Satia,Elvis M Irusen,Marwan M. Refaat,J Stephen Mikita,Maureen A. Smith,Dian Cohen,Per Olav Vandvik,Thomas Agoritsas,Thomas Agoritsas,Lyubov Lytvyn,Gordon H. Guyatt +19 more
TL;DR: This guideline aims to promptly and transparently translate potentially practice-changing evidence to usable recommendations for clinicians and patients.
Journal ArticleDOI
Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
TL;DR: Moderate-quality evidence suggests that daily use of oral finasteride increases hair count and improves patient and investigator assessment of hair appearance, while increasing the risk of sexual dysfunction.
References
More filters
Journal ArticleDOI
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
Journal ArticleDOI
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen B. Hulley,Deborah Grady,Trudy L. Bush,Curt D Furberg,David M. Herrington,Betty Riggs,Eric Vittinghoff +6 more
TL;DR: Treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease and the treatment did increase the rate of thromboembolic events and gallbladder disease.
Journal ArticleDOI
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Echt Ds,Philip R. Liebson,Mitchell Lb,Robert W. Peters,Obias-Manno D,Barker Ah,Arensberg D,Baker A,Lawrence S. Friedman,Greene Hl +9 more
TL;DR: There was an excess of deathsDue to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.
Journal ArticleDOI
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.
TL;DR: Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a timely fashion need access to better databases and new statistical techniques to assist them.
Journal ArticleDOI
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
David Atkins,Martin P Eccles,Signe Flottorp,Gordon H. Guyatt,David Henry,Suzanne Hill,Alessandro Liberati,Dianne L. O'Connell,Andrew D Oxman,Bob Phillips,Holger J. Schünemann,Holger J. Schünemann,Tessa Tan-Torres Edejer,Gunn Elisabeth Vist,John W Williams +14 more
TL;DR: The objective was to critically appraise six prominent systems for grading levels of evidence and the strength of recommendations as a basis for agreeing on characteristics of a common, sensible approach.